<DOC>
	<DOCNO>NCT00554411</DOCNO>
	<brief_summary>Hypothesis : Changing Travatan Z therapy increase tear film break time subject Xalatan therapy present ocular surface disease .</brief_summary>
	<brief_title>Assessing Ocular Surface Changes After Changing Glaucoma Medications</brief_title>
	<detailed_description>Patients take Xalatan monotherapy treat glaucoma present ocular surface disease advise switch medication Travatan Z . Test result record day medication change follow-up determine measurable change tear film break , corneal stain Ocular Surface Disease Index .</detailed_description>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Travoprost</mesh_term>
	<criteria>Xalatan monotherapy 1 18 month 18 year age old diagnose ocular surface disease special population child , pregnant female , prisoner , etc .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Travatan Z</keyword>
	<keyword>glaucoma</keyword>
	<keyword>tear film break time</keyword>
</DOC>